Possible risperidone poisoning in a dog
Gough, A.
Veterinary Record 155(5): 156
2004
ISSN/ISBN: 0042-4900 PMID: 15338714 Document Number: 581661
Document emailed within 1 workday
Related Documents
Borison, R.L. 1996: Changing antipsychotic medication: guidelines on the transition to treatment with risperidone. The Consensus Study Group on Risperidone Dosing Clinical Therapeutics 18(4): 592-607; discussion 591Chouinard, G.; Arnott, W. 1993: Clinical review of risperidone Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 38(Suppl 3): S89-S95
Heimberg, C.; Yearian, A.S. 1996: Risperidone-associated burning paraesthesia Journal of Clinical Psychopharmacology 16(6): 446-448
Bravo-Mehmedbasic, A. 2011: Risperidone in the treatment of schizophrenia Medicinski Arhiv 65(6): 345-347
Ereshefsky, L.; Lacombe, S. 1993: Pharmacological profile of risperidone Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 38(Suppl 3): S80-S88
Lee, D.W.; Fowler, R.B. 2003: Olanzapine/risperidone and diabetes risk Journal of Clinical Psychiatry 64(7): 847-8; Author Reply 848
Mazhar, M.N.; Resch, D.S. 2010: Risperidone induced ventricular tachycardia Psychopharmacology Bulletin 43(3): 82-83
Gleason, P.P.; Conigliaro, R.L. 1997: Neuroleptic malignant syndrome with risperidone PharmacoTherapy 17(3): 617-621
Waring, E.W.; Dewan, V.K.; Cohen, D.; Grewal, R. 1999: Risperidone as an adjunct to valproic acid Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 44(2): 189
Bruun, R.D.; Budman, C.L. 1996: Risperidone as a treatment for Tourette's syndrome Journal of Clinical Psychiatry 57(1): 29-31
Accardo, P. 2003: Risperidone in children with autism and serious behavioral problems Journal of Pediatrics 142(1): 86-87
Kim, K.; Aas, E. 2011: Cost-effectiveness analysis of olanzapine and risperidone in Norway Journal of Mental Health Policy and Economics 14(3): 125-135
Boon-Yasidhi, V.; Tarugsa, J.; Suwanwattana, C.; Soising, L. 2002: Risperidone in the treatment of autistic Thai children under 4 years of age Journal of the Medical Association of Thailand 85(Suppl): S784-S789
Henderson, D.C.; Goff, D.C. 1996: Risperidone as an adjunct to clozapine therapy in chronic schizophrenics Journal of Clinical Psychiatry 57(9): 395-397
Klebovich, A.ás.; Reszegi, C.A.; Zelkó, R.án. 2004: Utilization study of clozapine, olanzapine and risperidone in Hungary Acta Pharmaceutica Hungarica 74(4): 233-236
Kooptiwoot, S.; Settachan, T. 2000: Improvement of tardive dyskinesia with risperidone: a case report Journal of the Medical Association of Thailand 83(11): 1430-1432
Alderman, C.P.; Fraser, C.D. 1995: Use of risperidone with a patient sensitive to conventional neuroleptic drugs American Journal of Psychiatry 152(8): 1234-1235
Velázquez-Fragua, R.; Roche-Herrero, M.C.; Noval-Martín, S.; Muñoz-García, G.; Rubio-Rodríguez, F.; Martínez-Bermejo, A. 2008: Pseudotumor cerebri as side effect of treatment with risperidone Revista de Neurologia 46(12): 766-767
Pinninti, N.R.; Mago, R. 2005: Injection site pain with long-acting risperidone Journal of Clinical Psychiatry 66(5): 656-7; Author Reply 657
Chong, S.A.; Yap, H.L.; Low, B.L.; Choo, C.H.; Chan, A.O.; Wong, K.E.; Mahendran, R.; Chee, K.T. 1999: Clinical evaluation of risperidone in Asian patients with schizophrenia in Singapore Singapore Medical Journal 40(1): 41-43